New screening for primary aldosteronism in hypertension
Part of Hormones & metabolism clinical trials.
This trial looks for better ways to diagnose primary aldosteronism (PA), a common cause of high blood pressure that can be treated. It may help find people whose hypertension is caused by this condition so they can get the right treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have high blood pressure that is hard to control (over 150/100) or resistant to treatment.
- You have newly diagnosed high blood pressure.
- You have high blood pressure with low potassium levels (from causes like diuretics or naturally).
- You have high blood pressure and an adrenal gland growth (incidentaloma).
- You have high blood pressure and a family history of early hypertension or stroke before age 40.
- You have high blood pressure and sleep apnea.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a 2-day version of the oral salt loading test works as well as the standard 3-day test to diagnose primary aldosteronism (a common cause of high blood pressure). If effective, it could make diagnosis faster and easier for patients.
This study is developing a better blood test to diagnose primary aldosteronism, a condition where the adrenal glands produce too much of a hormone called aldosterone, causing high blood pressure. Researchers are comparing results from healthy volunteers and patients suspected of having this condition to find the right cutoff numbers for the new test.
This trial looks at whether adding spironolactone to your current blood pressure medicines works better for people with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure). You may qualify if you have this form of high blood pressure but have declined surgery or don't have an adenoma.
This study looks at better ways to diagnose primary aldosteronism when lab results suggest the condition but standard diagnosis criteria haven’t been met. It may help you understand what your hormone pattern means and whether you need specific treatment.
This trial tests whether a new drug called SAL0140 can safely lower blood pressure in people with primary aldosteronism, a condition where the body makes too much of a hormone that raises blood pressure. You'll take the study drug at different dose levels while your blood pressure and kidney function are monitored.
This trial studies people with high blood pressure caused by a hormone problem called primary aldosteronism. If you qualify, the study may help doctors learn better ways to identify and manage this specific cause of blood pressure elevation.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.